Navigation Links
Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
Date:3/4/2008

GREENWICH, Conn., March 4 /PRNewswire-FirstCall/ -- Oracle Healthcare Acquisition Corp. (the "Company") (OTC Bulletin Board: OHAQ) announced today that it has entered into an agreement with Precision Therapeutics, Inc. ("PTI") providing for the mutual termination of the Agreement and Plan of Merger, dated as of December 3, 2007 and amended on January 24, 2008 and February 25, 2008 (as amended, the "Merger Agreement"), by and among the Company, PTI Acquisition Sub, Inc. and PTI and the transactions contemplated thereby.

The Company and PTI determined that, due to currently prevailing market conditions, terminating the Merger Agreement was in the best interests of both the Company and PTI, as well as their respective stockholders.

In light of the termination of the Merger Agreement, the Company's board of directors has canceled the special meeting of stockholders of the Company that had been scheduled to occur on Wednesday, March 5, 2008 for the purpose of voting on the Merger Agreement.

Pursuant to the provisions of the Company's Amended and Restated Certificate of Incorporation, the Company will liquidate as promptly as practicable. The Company's board of directors has authorized the Company to commence a dissolution and liquidation process. This process will involve, among other things, the preparation of a plan of dissolution and a proxy statement by the Company (which will be subject to board approval), the filing of such proxy statement with, and (if applicable) clearance by, the Securities and Exchange Commission and a stockholders meeting to approve the dissolution and liquidation of the Company.

Forward Looking Statements:

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Readers are cautioned not to place undue reliance on any such forward-looking statements, each of which speaks only as of the date made. Such statements are subject to certain risks and uncertainties which are disclosed in the Company's SEC reports, including the Form 10-K for the year ended December 31, 2007.

Contact: President and Chief Operating Officer

Oracle Healthcare Acquisition Corp.

(203) 862-7900


'/>"/>
SOURCE Oracle Healthcare Acquisition Corp.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Oracle Introduces Remote Data Capture Onsite 4.5.3 With Extensive New Functionality for Investigative Site Personnel
2. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15%
3. Oracle Helps Mayo Clinic Improve Information Management
4. TCS, Oracle and DrugLogic Prescribe Safety in a Capsule(TM)
5. Cathedral Healthcare System to Pay U.S. $5.3 Million to Resolve Allegations Involving Inflated Charges to Obtain Higher Medicare Reimbursement
6. Bayer HealthCare and Juvaris BioTherapeutics Announce Major Licensing Agreement
7. Anthem Blue Cross and Blue Shields Promoting Healthcare Quality Program Improves Quality and Patient Safety in 19 Colorado Hospitals
8. Benefitfocus(R) Healthcare Video Portal Merges Community with Credibility
9. Prime Healthcare Services Enters Into Network Wide Contract With Aetna Health Plans
10. UPDATED: Catholic Healthcare West and SEIU Begin Negotiations for 15,000 Hospital Workers
11. Catholic Healthcare West and SEIU Begin Negotiations for 15,000 Hospital Workers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... ... , ... A new collaboration will give more researchers access to the largest ... analytics leader SAS will provide researchers worldwide with data management and analytics tools to ... , The DCRI and SAS share the goal of greater transparency and openness ...
(Date:5/4/2016)... ... May 04, 2016 , ... Slepkow Slepkow & ... one of the top website design companies to create a state of the ... to the law firm's main practice areas. These practice areas include: real estate, ...
(Date:5/4/2016)... ... May 04, 2016 , ... Francesca Loparco, Co-Founder of Queen City Dream Cars, ... same-day LASIK procedure at Christenbury Eye Center. The entrepreneur struggled with her ... surgery the same day as her in-office consultation and eye exam. Francesca’s eyesight was ...
(Date:5/4/2016)... ... 2016 , ... Advanced Spine & Sport Medical Rehabilitation Center, which is renowned ... a free seminar on stem cell injections. The seminar is scheduled for Wednesday, May ... Telephone Road, Suite 110, Ventura, CA. There are only 10 seats available. , ...
(Date:5/4/2016)... Lenexa, KS (PRWEB) , ... May 04, 2016 ... ... Transtem™ Patient 2016, a powerful cellular therapy software application that helps ... life-saving treatments to patients. , Since Transtem’s initial launch, Mediware has continued to ...
Breaking Medicine News(10 mins):
(Date:5/4/2016)... , May 4, 2016 BiondVax ... CEO, Dr. Ron Babecoff , will be attending the ... City . On Thursday, May 5, Dr. ... conference presented by Joseph Gunner & Co, taking ... BiondVax presentation that Dr. Babecoff will be using is downloadable ...
(Date:5/4/2016)... , May 4, 2016 ... addition of the  "Global Multiple Myeloma Market ... to their offering.       (Logo: ... Myeloma Market and Competitive Landscape Highlights 2016, ... products, Multiple Myeloma epidemiology, Multiple Myeloma market ...
(Date:5/3/2016)... , May 4, 2016 ... 154 pages, profiling 09 key companies and supported ... professional and in-depth study on the current state ... overview of the industry including definitions, classifications, applications ... analysis is provided for the international market including ...
Breaking Medicine Technology: